RxSight (RXST) Share-based Compensation (2020 - 2026)

RxSight's Share-based Compensation history runs 7 years deep, the most recent figure standing at $21.4 million for Q1 2026.

• Quarterly Share-based Compensation rose 199.72% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.4 million (down 20.97% YoY) and the FY2025 annual result came in at $17.8 million, down 27.75% from the prior year.
• Share-based Compensation was $21.4 million for Q1 2026 at RxSight, up from -$23.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $24.2 million in Q2 2025 and bottomed at -$23.8 million in Q4 2025.
• A 5-year average of $5.2 million and a median of $4.7 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2023 — Share-based Compensation jumped 3687.36% — and 2025, when it slumped 426.37%.
• RxSight's Share-based Compensation stood at $10.3 million in 2022, then soared by 52.69% to $15.7 million in 2023, then slumped by 53.73% to $7.3 million in 2024, then slumped by 426.37% to -$23.8 million in 2025, then surged by 190.04% to $21.4 million in 2026.
• Business Quant data shows RXST's Share-based Compensation at $21.4 million in Q1 2026, -$23.8 million in Q4 2025, and $2.0 million in Q3 2025.